Yuki Kurauchi

Dr. Yuki Kurauchi

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
RTReiho Tsutsumi
Reiho Tsutsumi
YHYuria Hori
Yuria Hori
Takahiro SekiTakahiro Seki
Takahiro Seki
YKYuki Kurauchi
Yuki Kurauchi
MSMasahiro Sato
Masahiro Sato
HKHiroshi Katsuki
Hiroshi Katsuki

3 May 2021 in Cells
Verified
Journal Article
Open access
PDF file
YHYuria Hori
Yuria Hori
RTReiho Tsutsumi
Reiho Tsutsumi
KNKento Nasu
Kento Nasu
Alex BoatengAlex Boateng
Alex Boateng
YAYasuhiko Ashikari
Yasuhiko Ashikari
Takahiro SekiTakahiro Seki
Takahiro Seki
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra. The inflammatory activation of microglia participates in dopaminergic neurodegeneration in PD. Therefore, chemicals that inhibit microglial activation are considered to have therapeutic potential for PD. Aromatic (ar)-turmerone is a main component of turmeric oil extracted from Curcuma longa and has anti-inflammatory activity in cultured microglia. The aims of the present study are (1) to investigate whether naturally occurring S-enantiomer of ar-turmerone (S-Tur) protects dopaminergic neurons in midbrain slice cultures and (2) to examine ar-turmerone analogs that have higher activities than S-Tur in inhibiting microglial activation and protecting dopaminergic neurons. R-enantiomer (R-Tur) and two analogs showed slightly higher anti-inflammatory effects in microglial BV2 cells. S- and R-Tur and these two analogs reversed dopaminergic neurodegeneration triggered by microglial activation in midbrain slice cultures. Unexpectedly, this neuroprotection was independent of the inhibition of microglial activation. Additionally, two analogs more potently inhibited dopaminergic neurodegeneration triggered by a neurotoxin, 1-methyl-4-phenylpyridinium, than S-Tur. Taken together, we identified two ar-turmerone analogs that directly and potently protected dopaminergic neurons. An investigation using dopaminergic neuronal precursor cells suggested the possible involvement of nuclear factor erythroid 2-related factor 2 in this neuroprotection.

Verified
Journal Article
Open access
PDF file
MFMadoka Fukaura
Madoka Fukaura
YIYoichi Ishitsuka
Yoichi Ishitsuka
SSSeiichi Shirakawa
Seiichi Shirakawa
NUNaoki Ushihama
Naoki Ushihama
YYYusei Yamada
Yusei Yamada
TITetsumi Irie
Tetsumi Irie
Niemann–Pick disease type C (NPC) is a recessive hereditary disease caused by mutation of the NPC1 or NPC2 gene. It is characterized by abnormality of cellular cholesterol trafficking with severe neuronal and hepatic injury. In this study, we investigated the potential of glycoprotein nonmetastatic melanoma protein B (GPNMB) to act as a biomarker reflecting the therapeutic effect of 2-hydroxypropyl-β-cyclodextrin (HP-β-CD) in an NPC mouse model. We measured serum, brain, and liver expression levels of GPNMB, and evaluated their therapeutic effects on NPC manifestations in the brain and liver after the intracerebroventricular administration of HP-β-CD in Npc1 gene-deficient (Npc1−/−) mice. Intracerebroventricular HP-β-CD inhibited cerebellar Purkinje cell damage in Npc1−/− mice and significantly reduced serum and cerebellar GPNMB levels. Interestingly, we also observed that the intracerebral administration significantly reduced hepatic GPNMB expression and elevated serum ALT in Npc1−/− mice. Repeated doses of intracerebroventricular HP-β-CD (30 mg/kg, started at 4 weeks of age and repeated every 2 weeks) drastically extended the lifespan of Npc1−/− mice compared with saline treatment. In summary, our results suggest that GPNMB level in serum is a potential biomarker for evaluating the attenuation of NPC pathophysiology by intracerebroventricular HP-β-CD treatment.

1 August 2019 in Journal of Functional Foods
Verified
Journal Article
Closed access
YKYuki Kurauchi
Yuki Kurauchi
Hari Prasad DevkotaHari Prasad Devkota
Hari Prasad Devkota
KHKengo Hori
Kengo Hori
YNYuiko Nishihara
Yuiko Nishihara
AHAkinori Hisatsune
Akinori Hisatsune
HKHiroshi Katsuki
Hiroshi Katsuki

29 March 2021 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
YYYusei Yamada
Yusei Yamada
YIYoichi Ishitsuka
Yoichi Ishitsuka
YKYuki Kondo
Yuki Kondo
SNShuichi Nakahara
Shuichi Nakahara
ANAsami Nishiyama
Asami Nishiyama
TITetsumi Irie
Tetsumi Irie

25 October 2019 in Molecules
Verified
Journal Article
Open access
PDF file
WSWataru Shida
Wataru Shida
HTHiroshi Tateishi
Hiroshi Tateishi
YTYurika Tahara
Yurika Tahara
Mikako FujitaMikako Fujita
Mikako Fujita
Doaa AlsaadiDoaa Alsaadi
Doaa Alsaadi
TAKASHI WATANABETAKASHI WATANABE
TAKASHI WATANABE
Despite the development of a range of anti-cancer agents, cancer diagnoses are still increasing in number, remaining a leading cause of death. Anticancer drug treatment is particularly important for leukemia. We screened Turkish plants and found the unique antileukemic activity of twig components in Turkish Caucasian beech, selectively inducing apoptosis in leukemia cells. This effect is unique among some kinds of beeches, presumably related to oxidative stress. This study would lead to effective use of discarded material, i.e., twig of beech, and a new anti-leukemic drug based on large tree.